Drug Chatter -- Tracking biopharma stock chatter

Profile for Neurocrine Biosciences, Inc. (NBIX)

« Back to company index

NBIX Chatter Timeline

Stock Ticker for NBIX

Most Active Tweeters for NBIX

UserTweets
@ConsumerFeed 17
@stocknewstimes 14
@SleekMoneycom 13
@dispatchtribune 12
@intercooleronli 11

Recent Tweets for NBIX

stocknewstimes @stocknewstimes
Reviewing Neurocrine Biosciences $NBIX & Its Competitors https://t.co/6IYOAEQkLt
November 16th 2017, 8:11pm
ahighelevation @ahighelevation
Strong Launch for INGREZZA in Tardive Dyskinesia https://t.co/DA44MINvdt $NBIX @davidbautz #biotech https://t.co/rzJd00Bvcu
November 16th 2017, 5:11pm
FancyFinancy @FancyFinancy
RT @ZacksAwareness: Strong Launch for INGREZZA in Tardive Dyskinesia https://t.co/ygnbtOdPMe $NBIX @davidbautz #biotech https://t.co/9V1qVV…
November 16th 2017, 3:11pm
ZacksAwareness @ZacksAwareness
Strong Launch for INGREZZA in Tardive Dyskinesia https://t.co/ygnbtOdPMe $NBIX @davidbautz #biotech https://t.co/9V1qVVzX9v
November 16th 2017, 3:11pm
zackcappsocial @zackcappsocial
Strong Launch for INGREZZA in Tardive Dyskinesia https://t.co/ovyV8y21iZ $NBIX @davidbautz #biotech https://t.co/9oMaeRWVqK
November 16th 2017, 2:11pm
InstitutionalZC @InstitutionalZC
Strong Launch for INGREZZA in Tardive Dyskinesia https://t.co/IwIUp1e0Nz $NBIX @davidbautz #biotech https://t.co/CQ5bn4BdIc
November 16th 2017, 2:11pm
cmiller1225 @cmiller1225
RT @zackcapp: Strong Launch for INGREZZA in Tardive Dyskinesia https://t.co/BT8bmTcA7s $NBIX @davidbautz #biotech https://t.co/rPksVGmyOC
November 16th 2017, 8:11am
zackcapp @zackcapp
Strong Launch for INGREZZA in Tardive Dyskinesia https://t.co/BT8bmTcA7s $NBIX @davidbautz #biotech https://t.co/rPksVGmyOC
November 16th 2017, 8:11am
stocknewstimes @stocknewstimes
FY2017 EPS Estimates for Neurocrine Biosciences, Inc. $NBIX Raised by Analyst https://t.co/3sEN5yJvVK
November 16th 2017, 7:11am
ledgerzette @ledgerzette
FY2017 Earnings Forecast for Neurocrine Biosciences, Inc. $NBIX Issued By Oppenheimer Holdings https://t.co/gBI2hgEQ7Q
November 16th 2017, 7:11am
SleekMoneycom @SleekMoneycom
FY2017 EPS Estimates for Neurocrine Biosciences, Inc. $NBIX Raised by Analyst https://t.co/RHwZbKMUXK
November 16th 2017, 7:11am
TranscriptDaily @TranscriptDaily
Neurocrine Biosciences, Inc. $NBIX Insider Sells $2,237,400.00 in Stock https://t.co/i81j01VY0B
November 16th 2017, 5:11am
RoboSchmobo @RoboSchmobo
RT @HowieRegay: Strong Launch for INGREZZA in Tardive Dyskinesia https://t.co/aB4eAbFr2f $NBIX @davidbautz #biotech https://t.co/qAPOjTQl45
November 15th 2017, 11:11pm
HowieRegay @HowieRegay
Strong Launch for INGREZZA in Tardive Dyskinesia https://t.co/aB4eAbFr2f $NBIX @davidbautz #biotech https://t.co/qAPOjTQl45
November 15th 2017, 11:11pm
stocknewstimes @stocknewstimes
Neurocrine Biosciences, Inc. $NBIX Holdings Raised by Pictet Asset Management Ltd. https://t.co/GhLimMhEaJ
November 15th 2017, 11:11pm
FancyFinancy @FancyFinancy
RT @PortfolioPenny: Strong Launch for INGREZZA in Tardive Dyskinesia https://t.co/etZEAo69G6 $NBIX @davidbautz #biotech https://t.co/T4Jy18…
November 15th 2017, 6:11pm
dispatchtribune @dispatchtribune
Neurocrine Biosciences, Inc. $NBIX Given a $85.00 Price Target by Oppenheimer Holdings, Inc. Analysts https://t.co/tU62ItzqYP
November 15th 2017, 6:11pm
WatchlistN @WatchlistN
Neurocrine Biosciences, Inc. $NBIX Given a $85.00 Price Target by Oppenheimer Holdings, Inc. Analysts https://t.co/zdjN0n7S9t
November 15th 2017, 6:11pm
PiggyBankPeople @PiggyBankPeople
Strong Launch for INGREZZA in Tardive Dyskinesia https://t.co/2D0N95nLrE $NBIX @davidbautz #biotech https://t.co/Njy9AnTctD
November 15th 2017, 6:11pm
PortfolioPenny @PortfolioPenny
Strong Launch for INGREZZA in Tardive Dyskinesia https://t.co/etZEAo69G6 $NBIX @davidbautz #biotech https://t.co/T4Jy18HeYn
November 15th 2017, 6:11pm
MariaDa18810214 @MariaDa18810214
Sphera Funds Management LTD Has Decreased Neurocrine Biosciences $NBIX Holding By $4.05 Million ...
November 15th 2017, 3:11pm
jimmiebjorling @jimmiebjorling
Strong Launch for INGREZZA in Tardive Dyskinesia $NBIX @davidbautz #biotech https://t.co/3FgUGiN10h https://t.co/laiWribSG4
November 15th 2017, 2:11pm
VCapital_invest @VCapital_invest
Strong Launch for INGREZZA in Tardive Dyskinesia $NBIX @davidbautz #biotech https://t.co/cwkHZXdtLN https://t.co/w1xve0uAfF
November 15th 2017, 2:11pm
MarieSm76375904 @MarieSm76375904
Healthcor Management LP Has Increased Neurocrine Biosciences $NBIX Position By $59.63 Million ...
November 15th 2017, 12:11pm
alphabetastock @alphabetastock
Neurocrine Biosciences, Inc. $NBIX – Do Investors Feel Confident About Stock’s Future Direction? https://t.co/Y35uIhRVhU
November 15th 2017, 12:11pm
SleekMoneycom @SleekMoneycom
Neurocrine Biosciences $NBIX Getting Somewhat Positive News Coverage, Study Finds https://t.co/Qu7T2Ye8sB
November 15th 2017, 9:11am
ledgerzette @ledgerzette
Neurocrine Biosciences, Inc. $NBIX Given “Buy” Rating at Needham & Company LLC https://t.co/S3p0xyyIXe
November 15th 2017, 12:11am
WeekHerald @WeekHerald
Neurocrine Biosciences, Inc. $NBIX Price Target Increased to $85.00 by Analysts at Barclays PLC https://t.co/sG0mXlKDlQ
November 15th 2017, 12:11am
stocknewstimes @stocknewstimes
Deutsche Bank AG Reaffirms Buy Rating for Neurocrine Biosciences, Inc. $NBIX https://t.co/u2h7HbgYP4
November 14th 2017, 11:11pm
WeekHerald @WeekHerald
Needham & Company LLC Reaffirms Buy Rating for Neurocrine Biosciences, Inc. $NBIX https://t.co/SFVcSGYvHB
November 14th 2017, 11:11pm
allenelkhorn @allenelkhorn
RT @DavidBautz: $NBIX 2Q17: 745 Ingrezza Rx's; 3Q17: ~5,100 Ingrezza Rx's
November 14th 2017, 8:11pm
ConsumerFeed @ConsumerFeed
Neurocrine Biosciences $NBIX – Investment Analysts’ Weekly Ratings Updates https://t.co/igTWGh5CIg #acn
November 14th 2017, 6:11pm
intercooleronli @intercooleronli
Neurocrine Biosciences $NBIX – Investment Analysts’ Weekly Ratings Updates https://t.co/83XrYTm6cF
November 14th 2017, 6:11pm
TheMarketsDaily @TheMarketsDaily
Neurocrine Biosciences $NBIX – Investment Analysts’ Weekly Ratings Updates https://t.co/dXnWsnY9es
November 14th 2017, 6:11pm
AmericanBanking @AmericanBanking
Neurocrine Biosciences $NBIX – Investment Analysts’ Weekly Ratings Updates https://t.co/aKzIwBs1g8
November 14th 2017, 6:11pm
CFinancialNews @CFinancialNews
Neurocrine Biosciences $NBIX – Investment Analysts’ Weekly Ratings Updates https://t.co/RTfdy1XHJj
November 14th 2017, 6:11pm
autisticnation1 @autisticnation1
I have a feeling $NBIX is being bought out. Stock drops 3 bucks today (not an unusual event) and co issues a press… https://t.co/5mSkeVYDaP
November 14th 2017, 5:11pm
imriyu @imriyu
@raiankanpai I'm not short on $NBIX. Is it really hard to look at chart ans see that it's works like placebo..
November 14th 2017, 5:11pm
kevinn8841 @kevinn8841
@imriyu you state "it gets worse over time". Looks like improvement to me. i think you're misunderstood on what a "washout period" is $NBIX
November 14th 2017, 3:11pm
ZolmaxNews @ZolmaxNews
Neurocrine Biosciences, Inc. $NBIX Given a $85.00 Price Target at Oppenheimer Holdings, Inc. https://t.co/gxcDjL38Qn
November 14th 2017, 3:11pm
intercooleronli @intercooleronli
Neurocrine Biosciences, Inc. $NBIX Given a $85.00 Price Target by Oppenheimer Holdings, Inc. Analysts https://t.co/tgD4u69Nl0
November 14th 2017, 3:11pm
CFinancialNews @CFinancialNews
Neurocrine Biosciences, Inc. $NBIX Given a $85.00 Price Target by Oppenheimer Holdings, Inc. Analysts https://t.co/EaCz2NtDaT
November 14th 2017, 3:11pm
RatingsNetwork @RatingsNetwork
Neurocrine Biosciences given $85.00 PT by Oppenheimer Holdings, Inc.. buy rating. https://t.co/jaFPeuHbqh $NBIX #NBIX
November 14th 2017, 3:11pm
imriyu @imriyu
$NBIX long-term results evaluating ingrezza show that it workes like placebo. sometimes it's even worse. and get wo… https://t.co/G5sjoptw3l
November 14th 2017, 2:11pm
pnani456 @pnani456
RT @odibro: $NBIX LT Results Evaluating INGREZZA® for the Trtmnt of Adults w/TD Published in the Journal of Clinical Psychiatry https://t.…
November 14th 2017, 2:11pm
odibro @odibro
$NBIX LT Results Evaluating INGREZZA® for the Trtmnt of Adults w/TD Published in the Journal of Clinical Psychiatry https://t.co/gwoPuyI3od
November 14th 2017, 2:11pm
SleekMoneycom @SleekMoneycom
Worth Venture Partners LLC Invests $702,000 in Neurocrine Biosciences, Inc. $NBIX Stock https://t.co/6w3nAFrrgq
November 14th 2017, 2:11pm
stocknewstimes @stocknewstimes
Worth Venture Partners LLC Invests $702,000 in Neurocrine Biosciences, Inc. $NBIX Stock https://t.co/lZdIZxY5GD
November 14th 2017, 2:11pm
SleekMoneycom @SleekMoneycom
Neurocrine Biosciences, Inc. $NBIX Receives “Outperform” Rating from Leerink Swann https://t.co/8dhpQkHsTG
November 14th 2017, 2:11pm
dispatchtribune @dispatchtribune
Neurocrine Biosciences’ $NBIX “Buy” Rating Reaffirmed at Citigroup Inc. https://t.co/MBGuDunWeE
November 14th 2017, 2:11pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.